(Q37724863)

22 August 2017

1 reference

title

Archaeal lipid mucosal vaccine adjuvant and delivery system (English)

1 reference

22 August 2017

1 reference

Girishchandra B Patel

series ordinal

1

1 reference

22 August 2017

Wangxue Chen

series ordinal

2

1 reference

22 August 2017

publication date

1 April 2010

1 reference

Expert Review of Vaccines

22 August 2017

published in

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

431-440

1 reference

Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?

22 August 2017

cites work

1 reference

Induction of secretory immunity and memory at mucosal surfaces

21 January 2018

1 reference

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

Recent advances in vaccine adjuvants

21 January 2018

1 reference

21 January 2018

1 reference

Oral immunization: an update

21 January 2018

1 reference

Mucosal delivery of vaccine antigens and its advantages in pediatrics

21 January 2018

1 reference

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

21 January 2018

1 reference

Immunization without needles

21 January 2018

1 reference

21 January 2018

1 reference

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

21 January 2018

1 reference

New generation of mucosal adjuvants for the induction of protective immunity

21 January 2018

1 reference

Mucosal immunosenescence: new developments and vaccines to control infectious diseases

21 January 2018

1 reference

Immunomodulators and delivery systems for vaccination by mucosal routes.

21 January 2018

1 reference

Needle-free vaccine delivery

21 January 2018

1 reference

Recent developments in particulate-based vaccines

21 January 2018

1 reference

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.

21 January 2018

1 reference

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

21 January 2018

1 reference

Mucosal vaccination against bacterial respiratory infections

21 January 2018

1 reference

Novel generations of influenza vaccines

21 January 2018

1 reference

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

21 January 2018

1 reference

Implication of nanoparticles/microparticles in mucosal vaccine delivery

21 January 2018

1 reference

Cationic liposomes as vaccine adjuvants

21 January 2018

1 reference

Is intranasal vaccination a feasible solution for tuberculosis?

21 January 2018

1 reference

New horizons in adjuvants for vaccine development

21 January 2018

1 reference

Novel approaches to vaccine delivery

21 January 2018

1 reference

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

21 January 2018

1 reference

Vaccine adjuvants revisited

21 January 2018

1 reference

Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres.

21 January 2018

1 reference

ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines

21 January 2018

1 reference

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

21 January 2018

1 reference

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

21 January 2018

1 reference

Safety of intranasally administered archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) vaccine in mice.

21 January 2018

1 reference

Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines

21 January 2018

1 reference

Structures of archaebacterial membrane lipids

21 January 2018

1 reference

Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems

21 January 2018

1 reference

Archaeosome adjuvants: immunological capabilities and mechanism(s) of action

21 January 2018

1 reference

Recent advances in structural research on ether lipids from archaea including comparative and physiological aspects

21 January 2018

1 reference

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

Archaeosome immunostimulatory vaccine delivery system

21 January 2018

1 reference

In vitro assessment of archaeosome stability for developing oral delivery systems.

21 January 2018

1 reference

Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles

21 January 2018

1 reference

Recombinant poxviruses as mucosal vaccine vectors

21 January 2018

1 reference

Bacteria-derived particles as adjuvants for non-replicating nasal vaccines

21 January 2018

1 reference

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

21 January 2018

1 reference

Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract

21 January 2018

1 reference

Immunostimulating complexes (ISCOMs) for nasal vaccination

21 January 2018

1 reference

Comparative properties and methods of preparation of lipid vesicles (liposomes).

21 January 2018

1 reference

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

21 January 2018

1 reference

Current options for vaccine delivery systems by mucosal routes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.34

1 reference

22 August 2017

1 reference